Asthme
2021 Canadian Thoracic Society Guideline – A focused update on the management of very mild and mild asthma, Connie L. Yang, Elizabeth Anne Hicks, Patrick Mitchell, Joe Reisman, Delanya Podgers, Kathleen M. Hayward, Mark Waite & Clare D. Ramsey Canadian Journal of Respiratory, Critical Care, and Sleep Medicine, 5:4, 205-245, DOI: 10.1080/24745332.2021.1877043
BCGuidelines.ca, Appendix C: Asthma medication table
RxFiles, COPD, NEW DRUGS, NEW DEVICES AND CONSIDERATIONS FOR BEST PRACTICE, September 2015
CONCLUSIONS: In patients with mild asthma, as-needed budesonide-formoterol provided superior asthma-symptom control to as-needed terbutaline, assessed according to electronically recorded weeks with well-controlled asthma, but was inferior to budesonide maintenance therapy. Exacerbation rates with the two budesonide-containing regimens were similar and were lower than the rate with terbutaline. Budesonide-formoterol used as needed resulted in substantially lower glucocorticoid exposure than budesonide maintenance therapy.